opti-free enzymatic cleaner
alcon laboratories australia pty ltd (nz) - pancreatin 1.25mg equivalent to nlt1.75 bpunits protease activity(105.5 µg tyr/min) - tablet for contact lens solution - 1.25 mg - active: pancreatin 1.25mg equivalent to nlt1.75 bpunits protease activity(105.5 µg tyr/min) excipient: citric acid ethanol as dehydrated alcohol, not present in final product macrogol 3350 povidone sodium bicarbonate sucrose
opti-free supra clens
alcon laboratories australia pty ltd (nz) - pancreatin equivalent to 950 µg tyrosine/min/ml(1700 alconunits) - contact lens solution - active: pancreatin equivalent to 950 µg tyrosine/min/ml(1700 alconunits) excipient: borax hydrochloric acid propylene glycol sodium hydroxide water
pancrex v
new zealand medical & scientific ltd - pancreatin 86.6mg (amylase 1,700u, lipase 1,900u, protease 110u/porcine) - enteric coated tablet - active: pancreatin 86.6mg (amylase 1,700u, lipase 1,900u, protease 110u/porcine) excipient: acacia calcium carbonate gelatin opaseal. enteric coat. povidone purified talc stearic acid sucrose urethane dimethacrylate luting resin
pancrex v forte
new zealand medical & scientific ltd - pancreatin 250mg (amylase 5000u, lipase 5600u, protease 330u/porcine) - enteric coated tablet - active: pancreatin 250mg (amylase 5000u, lipase 5600u, protease 330u/porcine) excipient: acacia calcium carbonate gelatin opaseal. enteric coating. lactose monohydrate povidone purified talc stearic acid sucrose urethane dimethacrylate luting resin
panzytrat 10,000
pharmaco (nz) ltd - pancreatin (126.875-142.100mg (10,000ulipase, 9,000uamylase,500uprotease) - modified release capsule - active: pancreatin (126.875-142.100mg (10,000ulipase, 9,000uamylase,500uprotease) excipient: colloidal silicon dioxide crospovidone gelatin glycol montanate iron oxide black iron oxide red magnesium stearate methacrylic acid copolymer microcrystalline cellulose purified talc simeticone titanium dioxide triethyl citrate
polyzym enzymatic cleaner
alcon laboratories australia pty ltd (nz) - pancreatin 2.5mg - tablet for contact lens solution - 2.5 mg - active: pancreatin 2.5mg excipient: citric acid macrogol 3350 povidone sodium bicarbonate sucrose
tryplase capsules
msd animal health uk limited - pancreatin - capsule, hard - gastrointestinal - cats, dogs
mezym forte tablets film-coated
berlin-chemie ag - pancreatin (lipase, amylase, protease) - tablets film-coated - 3500iu+ 4200iu+ 250iu (20/2x10/) in blister, (20/1x20/) in blister, (40/4x10/) in blister, (40/2x20/) in blister, (80/8x10/) in
mezym forte tablets film-coated
berlin-chemie ag - pancreatin (lipase, amylase, protease) - tablets film-coated - 3500u+ 4200u+ 250u
creon 35,000
viatris limited - pancreatin 420mg (amylase 25,200 ph eur u, lipase 35,000 ph eur u, protease 1,400 ph eur u.); pancreatin 420mg (amylase 25,200 ph eur u, lipase 35,000 ph eur u, protease 1,400 ph eur u.) - modified release capsule - 420 mg - active: pancreatin 420mg (amylase 25,200 ph eur u, lipase 35,000 ph eur u, protease 1,400 ph eur u.) excipient: cetyl alcohol dimeticone gelatin hypromellose phthalate iron oxide black iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate titanium dioxide triethyl citrate active: pancreatin 420mg (amylase 25,200 ph eur u, lipase 35,000 ph eur u, protease 1,400 ph eur u.) excipient: cetyl alcohol dimeticone gelatin hypromellose phthalate iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate triethyl citrate - creon is indicated for the treatment of pancreatic exocrine insufficiency (pei) in paediatric and adult patients. pancreatic exocrine insufficiency is often associated with, but not limited to: · cystic fibrosis · chronic pancreatitis · post-pancreatectomy · post-gastrointestinal bypass surgery ,(e.g. billroth ii, gastroenterostomy) · ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).